Norges Bank’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Norges Bank’s Portfolio GRTS Stock Details GRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-10,000	Closed	-$142K	–	2138
2018 Q3	$142K	Buy	+10,000	New	+$142K	﹤0.01%	2123

Other funds holding GRTS

Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Norges Bank's GRTS Position: Q4 2018 in Review

Norges Bank sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2018, closing a stake of 10,000 shares — an estimated $142K sold.

Norges Bank first reported a position in GRTS in Q3 2018 and held it in 1 quarter. The position peaked at $142K in Q3 2018. 52 funds tracked by Wall St. Rank hold GRTS as of Q4 2018.

Norges Bank reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Norges Bank sold 10,000 Gritstone bio, Inc. Common Stock shares in Q4 2018, an estimated $142K.
Norges Bank first reported a position in Gritstone bio, Inc. Common Stock in Q3 2018 and held it in 1 quarter.
Norges Bank's Gritstone bio, Inc. Common Stock position peaked at $142K in Q3 2018.
52 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2018.

Based on Norges Bank's 13F filing for Q4 2018, filed 8 Feb 2019.